articlePubMedJul 1, 2003Closed access

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Pacific Northwest Diabetes Research Institute

PubMed
Indexed inpubmed

Abstract

The WFDC2 (HE4) gene is amplified in ovarian carcinomas, whereas its expression in normal tissues, including ovary, is low. Although the function of the HE4 protein is unknown,it is a member of a family of stable 4-disulfide core proteins that are secreted at high levels. We therefore performed experiments to explore whether quantitation of HE4 protein levels in serum can be used as a biomarker for ovarian carcinoma. A fusion gene was constructed encoding the HE4 protein fused to a gene encoding the murine IgG2a Fc domain. Subsequently, protein produced in mammalian cells was purified by affinity chromatography and used to immunize mice to generate hybridomas specific for HE4. Hybridoma supernatants were…

Citation impact

719
total citations
FWCI
15.85
Percentile
100%
References
30
Citations per year

Authors

9

Topics & keywords

Keywords
  • Fusion protein
  • Biomarker
  • Monoclonal antibody
  • Antibody
  • Ovarian carcinoma
  • Epitope
  • Ovarian cancer
  • Molecular biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.